Ignite Creation Date:
2025-12-24 @ 9:24 PM
Ignite Modification Date:
2026-01-02 @ 4:11 PM
Study NCT ID:
NCT03007732
Status:
COMPLETED
Last Update Posted:
2025-12-05
First Post:
2016-08-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pembrolizumab +/- SD-101 in Hormone-Naïve Oligometastatic Prostate Cancer With RT and iADT
Sponsor:
David Oh
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-05-17
Start Date Type:
ACTUAL
Primary Completion Date:
2025-03-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-03-31
Completion Date Type:
ACTUAL
First Submit Date:
2016-08-05
First Submit QC Date:
None
Study First Post Date:
2017-01-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2025-11-14
Results First Submit QC Date:
None
Results First Post Date:
2025-12-05
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-02
Last Update Post Date:
2025-12-05
Last Update Post Date Type:
ESTIMATED